Upcoming Event

Management of Legionella in Water Systems - Meeting 2

Study in Progress: Public Meeting
Topics:
May 7, 2018
See on google maps

Location: Keck Center of the National Academies
500 Fifth St. NW Washington DC 20001

We invite you to join the open session of our second committee meeting. Please our tentative agenda below. See more information about this project and subscribe for updates here. You may attend in person or online via web conference. Registration is required to attend: either to have your name on the building's security list, or to receive the web conference link. Seating is limited at our meeting space. We expect to record and post presentations online after the meeting. Please contact Senior Project Assistant, Remy Chappetta, at rchappetta@nas.edu with any questions regarding meeting logistics. Tentative Agenda (as of 4 Apr.) May 7 Open Session E St. Conference Room 8:45 Doors Open 9:00?10:00 Environmental and Clinical Legionella Data Janet Stout, Special Pathogens Lab 10:00?10:15 Break 10:15?11:15 Legionella Management in Buildings: the roles of Plumbing and Policies Tim Keane, Legionella Risk 11:15?12:15 Barriers to Better Building Management for Legionella: Water Safety Plans Jennifer Clancy, ESPRI 12:15?1:15 Lunch (available for purchase in the Keck Center Atrium) 1:15?3:45 Panel on Guidance Documents for Legionella Management Christopher Crawford and Bruce Gutelius, NYC Cooling Tower Regulations Jessica Evans, NSF 453 and 444 Janet Stout, ASHRAE 188 and 12-2000 David Krause, AIHA 2015 Shantini Gamage and Oleh Kowalskyj, 2014 DVA Directive 3:45?4:00 Break 4:00?5:00 Open Mic Session 5:00 Adjourn Questions each panelist is asked to address in 30 minutes: ? What is in the guidance? ? What water systems they are applicable to? (everything, cooling towers, water supplies, etc.) ? What organisms are addressed? (L, all OPPPs, etc.) ? Do they recommend environmental monitoring? If so, by what methods? ? Does your guidance specify levels of legionella above which certain actions should be taken? ? How is it similar to/different than other guidances? ? Who has to comply with it? (no one, certain hospitals, federal buildings, a whole country) ? How widespread is implementation? (not widespread, here and there, everywhere) ? How enforceable is it? (not enforceable, very enforceable) ? Have there been any pitfalls, loopholes, or other unanticipated trade-offs or consequences of the guidance? ? What has been the outcome of using this guidance/policy/regulation? (we recognize that panelists may not be able to address this yet)